Key takeaways
Three things to remember
- 01
Homocysteine is a metabolic byproduct that accumulates when B-vitamin status (folate, B12, B6) is inadequate; higher levels are associated with vascular and brain health risks.
- 02
Levels above 10 micromol/L are worth addressing; higher levels are associated with greater dementia and cardiovascular risk in observational studies.
- 03
B12, methylfolate, and B6 supplementation typically reduces homocysteine by 25-30% within 4-8 weeks, making it a useful marker of B-vitamin status, though lowering it has not been shown to prevent cardiovascular events.
How it works
The Mechanism
Homocysteine forms from methionine, an essential amino acid abundant in meat and eggs. After methionine is used in cellular processes, it leaves behind homocysteine as a metabolic intermediate. Two recycling pathways clear it: remethylation (which converts it back to methionine using folate, B12, and the MTHFR enzyme) and transsulfuration (which converts it to cysteine using B6 and B2).
When these pathways are impaired, whether by low B-vitamin intake, genetic variants in the MTHFR gene, kidney dysfunction, or high protein intake without adequate micronutrient support, homocysteine accumulates. In lab studies, elevated homocysteine appears to irritate the endothelium (the inner lining of blood vessels) and make platelets stickier, which is one proposed way it could contribute to atherosclerosis and clotting.
The brain is particularly vulnerable. The VITACOG trial (Smith et al., 2010, Oxford) found that B-vitamin supplementation in people with mild cognitive impairment significantly slowed brain atrophy in those with elevated baseline homocysteine, suggesting that elevated homocysteine may be a modifiable contributor to faster brain shrinkage. In observational studies, higher levels are associated with greater risk of dementia.
In practice
Why It Matters
Elevated homocysteine is often a B-vitamin deficiency in disguise, and it is fixable in weeks.
Homocysteine is an underused biomarker that sits at the intersection of cardiovascular and cognitive risk. Because it responds directly to B-vitamin status, it is modifiable: B12, folate, and B6 often lower it within weeks. Lowering it has not, however, been shown to reduce heart attacks or strokes in large B-vitamin trials, so treat it as a marker of B-vitamin status and one piece of context, not a standalone target.
Common misconception
Most people associate homocysteine only with heart disease and assume it is only relevant after a cardiac event. In practice, it is also linked to cognitive aging, though the evidence is mostly observational and the benefit of lowering it is not established outside people with low B12 or folate. It is also not a dietary fat or cholesterol issue, so standard lipid-focused advice misses it entirely.
Reference ranges
What a Healthy Range Looks Like
Elevated
>15 µmol/L
Hyperhomocysteinemia: significantly elevated cardiovascular and cognitive risk
Borderline
10-15 µmol/L
Above optimal; B-vitamin optimization is indicated
Acceptable
7-10 µmol/L
Within normal clinical range; lower end is preferable
Optimal
<7 µmol/L
Associated with lowest cardiovascular and cognitive risk in population data
Most labs flag homocysteine above 15 micromol/L as high; many researchers now consider anything above 10 as suboptimal. The functional target for cardiovascular and cognitive protection is below 7-8 micromol/L. Response to B-vitamin supplementation is rapid: most people see meaningful reductions within 4-8 weeks.
Signs it is disrupted
- No specific symptoms at mildly elevated levels; it is a silent risk factor like high blood pressure
- Tingling or numbness in extremities can indicate concurrent B12 deficiency driving homocysteine elevation
- Fatigue and brain fog that do not resolve with adequate sleep may reflect underlying B12 or folate insufficiency
- History of early cardiovascular disease, stroke, or blood clots in first-degree relatives
- Known MTHFR genetic variant (especially compound heterozygous or homozygous C677T) without B-vitamin optimization
What moves it
How to Improve It
Folate (B9). 400-800 mcg of methylfolate daily (the bioactive form, especially important for MTHFR variants) is the most potent single nutrient for lowering homocysteine, reducing levels by 25% on average in studies by Wald et al. (2001).
Vitamin B12. 500-1,000 mcg of methylcobalamin (not cyanocobalamin) daily addresses B12 deficiency, which is extremely common in people over 50 and in those following plant-based diets.
Vitamin B6. 10-25 mg of B6 (pyridoxine) daily supports the transsulfuration pathway; works synergistically with folate and B12, as the Homocysteine Lowering Trialists Collaboration (2002) showed that combining all three is more effective than any alone.
Increase whole food protein variety. Ensuring adequate B-vitamin intake from leafy greens, legumes, eggs, and fortified foods supports both remethylation pathways without requiring high-dose supplements.
Reduce alcohol. Chronic alcohol intake impairs B-vitamin absorption and depletes folate, both of which elevate homocysteine; even moderate drinking can elevate levels in B-vitamin-marginal individuals.
Go deeper